Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 146.30M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 41.70B |
| Baxter International, Inc. | 10.18B |
| Bruker Corp. | 5.547B |
| Catalyst Pharmaceuticals, Inc. | 2.990B |
| Agios Pharmaceuticals, Inc. | 1.638B |
Market Cap Related Metrics
| PS Ratio | 0.6412 |
| PEG Ratio | -0.0019 |
| Price | 8.58 |
| Earnings Yield | -193.7% |
| PEGY Ratio | -0.0019 |